PhD, University of Rochester Postdoc- Harvard Medical School- DFCI Professor, Dept. of Pharmacology David and Margaret Turley Grohne Chair in Basic Cancer Research Associate Director for Basic Research, University of Colorado Cancer Center
Jessica Hsu
Graduate Student Pharmacology Program
BS, University of California, Berkeley Project Focus: The role of SIX1 in RMS progressing using zebrafish and mouse models of rhabdomyosarcoma (collaboration with Artinger Lab)
Funding: CCTSI fellowship
Connor Hughes
MSTP (MD/PhD)/ Graduate Student Pharmacology Program BS, University of Richmond
Project Focus: Tumor Heterogeneity/How EMT in Carcinoma cells influences neighboring Tumor Cells as well as the microenvironment
Funding : F30 NRSA NCI "Investigating the role of Eya3 in the regulation of innate immune signaling cascades in triple negative breast cancer"
Anthony Mangan
Postdoctoral Fellow
BS Biology, BS Chemistry, St. John FIsher College MS Biochemistry, Rochester Institute of Technology PhD Molecular Biology, University of Colorado - Anschutz Medical Campus
Project Focus: Novel therapeutics for rhabdomyosarcoma
Funding : T32 in Cancer Biology
Stephen Connor Purdy
Graduate Student Cancer Biology Program
BS Pharmaceutical Sciences, Purdue University
Project Focus: Targeting epithelial-mesenchymal plasticity to reduce metastasis and chemoresistance in breast cancer.
Funding: T32/Cancer Center Fellowship in Cancer Biology
Art Wolin
Graduate Student Molecular Biology Program
B.S. Northern Michigan University M.S. University of Michigan
Genetic and pharmacological methods to decipher the role(s) of Eya2 in brain cancers
Graduate Student Molecular Biology Program
BS in Biochemistry from Azusa Pacific University
Project Focus: Understanding the role of EYA3 in immune cell populations and their response to tumors
Kaiah Fields
Graduate Student Pharmacology Program
BS in Molecular and Cellular Biology, University of Illinois at Urbana-Champaign
Project Focus: EMT and tumor heterogeneity/ Identifying novel means to target tumor cell crosstalk and heterogeneity
Funding: T32 in Pharmacology
Brock Armstrong
PRA Lab Manager BS Molecular Cellular and Developmental Biology, CU-Boulder
Recent Ford Lab alumni (2019-present)
Hengbo Zhou
Current Position:
Postdoctoral fellow with Timothy Padera (MGH/Harvard Medical School) and Matthew Vander Heiden (MIT/Koch Institute)
In the Ford lab: 2015-2020; PhD Cancer Biology
Project Focus in Ford Lab: Dissecting the role of the SIX1/EYA complex in tumor progression and identifying novel means to target it
Funding: NCI F99 (Ford lab) /K00 (postdoc)
Michael Oliphant
Current Position:
Postdoctoral Fellow with Senthil Muthuswamy and Joan Brugge, Harvard Medical School
In the Ford lab: 2013-2019; PhD in Integrated Physiology
Project Focus: Regulation of Late Stage Metastasis in Breast Cancer
Funding: NCI F99 (Ford lab)/K00 (postdoc)
Melanie Vincent
Current Position:
Scientist III at Vigeo Therapeutics, Cambridge, MA
PhD, Albany Medical College
In the Ford lab: 2014-2019; Postdoctoral Fellow
Project Focus: Group 3 Medulloblastoma Progression
Funding while in Ford lab: Alex's Lemonade Stand Foundation Postdoctoral Fellowship
Taylor Hotz
Current Position:
PRA at Broad Institute, MIT
BA, University of Colorado Boulder
In the Ford Lab: Professional Research Assistant
Project Focus: Elucidating mechanisms by which Eya proteins influence tumor progression
Deguang Kong
Deguang Kong
Current Position:
Faculty at Renmin Hospital, Wuhan, China
MS and PhD, Huazhong University of Science and Technology
In the Ford lab: Visiting Graduate Student (2018-2019)
Project Focus: Tumor Cell Crosstalk and EMT in Metastasis/ VEGFC-GLI signaling